242 related articles for article (PubMed ID: 28571839)
1. [Perception of glaucoma and therapeutic adherence: A multicenter observational study].
Chiche A; Martin G; Brasnu de Cenival E; Rousseau A; Giocanti A; Fel A; Kallel S; Lombardi M; Hamard P; Baudouin C; Labbe A
J Fr Ophtalmol; 2017 Jun; 40(6):477-486. PubMed ID: 28571839
[TBL] [Abstract][Full Text] [Related]
2. Psychometric Properties of the Reduced Version of the Glaucoma Treatment Compliance Assessment Tool (GTCAT).
Barker GT; Mansberger SL
Ophthalmic Epidemiol; 2019 Feb; 26(1):55-62. PubMed ID: 30204034
[TBL] [Abstract][Full Text] [Related]
3. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
Rees G; Leong O; Crowston JG; Lamoureux EL
Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
[TBL] [Abstract][Full Text] [Related]
4. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
[TBL] [Abstract][Full Text] [Related]
5. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
[TBL] [Abstract][Full Text] [Related]
6. [Impact of glaucoma medications and ocular surface disease on the quality of life of glaucoma patients in the district of Sousse (Tunisia)].
Leila K; Gatfaoui F; Mahjoub A; Yakoubi S; Krifa F; Ghorbel M; Mahjoub H
J Fr Ophtalmol; 2019 May; 42(5):464-470. PubMed ID: 30928241
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.
Olthoff CM; Hoevenaars JG; van den Borne BW; Webers CA; Schouten JS
Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):235-43. PubMed ID: 18802720
[TBL] [Abstract][Full Text] [Related]
8. Adherence to glaucoma medication, illness perceptions, and beliefs about glaucoma: Attitudinal perspectives among Turkish population.
Guven S; Koylu MT; Mumcuoglu T
Eur J Ophthalmol; 2021 Mar; 31(2):469-476. PubMed ID: 32019338
[TBL] [Abstract][Full Text] [Related]
9. A study of the association between patterns of eye drop prescription and medication usage in glaucoma subjects.
Kawai-Tsuboi N; Kawai M; Minami Y; Yoshida A
J Glaucoma; 2015 Mar; 24(3):202-6. PubMed ID: 23807351
[TBL] [Abstract][Full Text] [Related]
10. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.
Sanchez FG; Mansberger SL; Newman-Casey PA
J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.
Sleath B; Blalock SJ; Carpenter DM; Sayner R; Muir KW; Slota C; Lawrence SD; Giangiacomo AL; Hartnett ME; Tudor G; Goldsmith JA; Robin AL
Ophthalmology; 2015 Apr; 122(4):748-54. PubMed ID: 25542521
[TBL] [Abstract][Full Text] [Related]
12. Multicenter study of compliance and drop administration in glaucoma.
Kholdebarin R; Campbell RJ; Jin YP; Buys YM
Can J Ophthalmol; 2008 Aug; 43(4):454-61. PubMed ID: 18711461
[TBL] [Abstract][Full Text] [Related]
13. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
[TBL] [Abstract][Full Text] [Related]
14. [Compliance with medical treatment in primary open-angle glaucoma in Lomé].
Santos MA; Ayena DK; Kuaovi KR; Vonor K; Djagnikpo A; Balo KP
J Fr Ophtalmol; 2016 May; 39(5):459-66. PubMed ID: 27180648
[TBL] [Abstract][Full Text] [Related]
15. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.
Park MH; Kang KD; Moon J;
Jpn J Ophthalmol; 2013 Jan; 57(1):47-56. PubMed ID: 23065047
[TBL] [Abstract][Full Text] [Related]
16. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
[TBL] [Abstract][Full Text] [Related]
17. Psychometric Properties of the Glaucoma Treatment Compliance Assessment Tool (GTCAT) in a Brazilian Population.
Abe RY; Wen LC; Barker GT; Mansberger SL
J Glaucoma; 2018 Mar; 27(3):257-265. PubMed ID: 29369851
[TBL] [Abstract][Full Text] [Related]
18. Evaluating eye drop instillation technique in glaucoma patients.
Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
[TBL] [Abstract][Full Text] [Related]
19. Glaucoma patient expression of medication problems and nonadherence.
Slota C; Sayner R; Vitko M; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Sleath B
Optom Vis Sci; 2015 May; 92(5):537-43. PubMed ID: 25875690
[TBL] [Abstract][Full Text] [Related]
20. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
